Better Therapeutics (BTTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 2 101 sessions, November 6, 2025 to November 6, 2026
- Largest daily move
- +100% close of March 23, 2026
- 1-year change
- +0% closing prices, November 6, 2025 to November 6, 2026
- 1-month change
- +0% closing prices, September 24, 2026 to November 6, 2026
Company Description
Better Therapeutics (OTC: BTTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $5.5K.
BTTX gained 0.0% in the 12 months to November 6, 2026. The last closing price was $0.0001.
For FY2022, Better Therapeutics reported net income of -$39.8M and diluted earnings per share of -$1.69.
This page collects what Stock Titan holds for BTTX, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
Better Therapeutics (BTTX) closed at $0.0001 on November 6, 2026. In the 12 months to November 6, 2026, the price gained 0.0%.
BTTX Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Better Therapeutics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include partnership, fda approval. View all BTTX news →
SEC Filings
Financial Highlights
Better Therapeutics reported operating income of -$38.3M in FY2022, and net income was -$39.8M. Diluted earnings per share stood at -$1.69. The company generated -$28.9M in operating cash flow. The current ratio was 1.37, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Better Therapeutics (BTTX) currently stands at 1.0 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for Better Therapeutics (BTTX) currently stands at 1.0 days, down 55.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 23.0 days.
BTTX Company Profile & Sector Positioning
Better Therapeutics (BTTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BTTX often look at related companies in the same sector, including LadRx Corporation (LADX), NovAccess Global Inc (XSNX), Scorpius Holdings Inc (SCPX), IO Biotech Inc (IOBTQ), and Kaleido Biosciences Inc (KLDO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BTTX's relative position within its industry.